A case report of long-term successful stereotactic arrhythmia radioablation in a cardiac contractility modulation device carrier with giant left atrium, including a detailed dosimetric analysis
IntroductionCatheter ablation (CA) is the current standard of care for patients suffering drug-refractory monomorphic ventricular tachycardias (MMVTs). Yet, despite significant technological improvements, recurrences remain common, leading to increased morbidity and mortality. Stereotactic arrhythmi...
Main Authors: | Mario Levis, Veronica Dusi, Massimo Magnano, Marzia Cerrato, Elena Gallio, Alessandro Depaoli, Federico Ferraris, Gaetano Maria De Ferrari, Umberto Ricardi, Matteo Anselmino |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.934686/full |
Similar Items
-
Interobserver variability in target definition for stereotactic arrhythmia radioablation
by: Martijn H. van der Ree, et al.
Published: (2023-09-01) -
Editorial: Stereotactic radioablation of cardiac arrhythmias: pros and cons
by: Maria Lucia Narducci, et al.
Published: (2023-06-01) -
Stereotactic Arrhythmia Radioablation as a Novel Treatment Approach for Cardiac Arrhythmias: Facts and Limitations
by: Marina Chalkia, et al.
Published: (2021-10-01) -
Stereotactic Arrhythmia Radioablation Treatment of Ventricular Tachycardia: Current Technology and Evolving Indications
by: Fabrizio Guarracini, et al.
Published: (2023-04-01) -
Dose escalation for stereotactic arrhythmia radioablation of recurrent ventricular tachyarrhythmia - a phase II clinical trial
by: Boldizsar Kovacs, et al.
Published: (2023-11-01)